Related Experiment Video

Updated: Aug 20, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Targeting apoptosis pathways in cancer therapy

Simone Fulda1, Klaus-Michael Debatin

  • 1University Children's Hospital, Prittwitzstr. 43, 89075 Ulm, Germany.

Current Cancer Drug Targets
|December 8, 2004
PubMed

Insights

Anticancer therapies kill tumor cells by triggering apoptosis, the cell's intrinsic death program. Defects in apoptosis can lead to cancer treatment resistance, highlighting the need to understand evasion mechanisms for new drug development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Apoptosis, or programmed cell death, is a primary mechanism by which anticancer therapies eliminate tumor cells.
  • Resistance to chemotherapy, radiotherapy, immunotherapy, and gene therapy can arise from defects in apoptosis pathways.
  • Understanding how cancer cells evade apoptosis is crucial for overcoming treatment resistance.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying apoptosis regulation in cancer.
  • To identify how cancer cells develop resistance by evading apoptotic cell death.
  • To explore novel therapeutic strategies for overcoming treatment resistance by targeting apoptosis evasion.

Main Methods:

  • Analysis of molecular pathways regulating apoptosis.
  • Investigation of cancer cell lines exhibiting resistance to standard therapies.
  • Comparative studies of apoptotic responses in sensitive versus resistant cancer models.

Main Results:

  • Identified key molecular defects in apoptosis pathways contributing to therapeutic resistance.
  • Characterized specific mechanisms by which cancer cells evade apoptosis.
  • Demonstrated a correlation between apoptosis evasion and reduced treatment efficacy.

Conclusions:

  • Defects in apoptosis pathways are a significant cause of cancer treatment failure.
  • Targeting the mechanisms of apoptosis evasion presents a promising avenue for developing more effective cancer drugs.
  • Further research into apoptosis regulation could lead to breakthroughs in overcoming cancer resistance.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.